Our standards.

A physician reviews every case.

Nothing is prescribed without a physician review of intake, history, medication list, and relevant labs. No exceptions, no template flows, no “health coach” intermediaries serving as a prescribing shortcut. Every dose, peptide, and cycle is signed off by a licensed physician with training specific to peptide therapy.

The physician who prescribes your protocol is the physician who follows up with you and adjusts it. We don’t hand care off to a rotating staff.

503A and 503B pharmacies only.

Every compounded peptide we prescribe is dispensed through a licensed 503A or 503B pharmacy that we have personally vetted. We review:

• State and federal compounding licenses
• Facility inspection history
• Third-party testing protocols (potency, sterility, endotoxin)
• Source of active pharmaceutical ingredients (API)
• Certificate of analysis documentation for each lot

We do not ship “research-grade” product. We do not sell peptides outside of an established patient relationship. We do not prescribe to patients who are concurrently using underground-sourced peptides, because we can’t assure what’s actually in them.

Honest limits on scope.

There are peptides we don’t work with, and the reasons matter:

• Peptides with insufficient human safety data. If the only available data is rodent models, we’re not comfortable prescribing, no matter how promising the mechanism looks.
• Peptides outside the compounding pathway. If a peptide can’t be legally prescribed and dispensed through a licensed pharmacy, we don’t prescribe it.
• Peptides for indications outside our scope. We’re a peptide clinic, not an oncology or psychiatric practice. Certain applications belong elsewhere.

If you ask about a peptide we don’t work with, we’ll tell you why — honestly. It is a useful way to evaluate any clinic.

We tell you how much we actually know.

Every peptide profile in our library and every consultation conversation includes an explicit weighting of the evidence: strong human data, limited human data, encouraging preclinical only, or mostly practitioner experience. The same peptide might be “appropriate” at one level of confidence for one patient and “not yet” for another.

Our medical team updates this weighting as literature evolves. When something we previously recommended is contradicted by new evidence, we say so publicly and update our protocols.

No set-and-forget protocols.

Peptides are not supplements to take indefinitely and forget about. Our programs include structured check-ins, repeat labs where clinically indicated, and formal mid-cycle reviews. If you aren’t seeing the expected response, we find out why — and we change the plan.

Patients who consistently miss check-ins are paused, not auto-refilled. This is a safety policy, not a business policy.

We know what we’re not.

We are not a primary care clinic, an endocrinology practice, a psychiatric practice, or an oncology practice. We coordinate with these specialists frequently and refer out readily when peptides aren’t the right answer.

Many patients come in wanting a peptide for something that is better addressed through hormone optimization, behavioral medicine, or standard primary care. When that’s the case, we say so — even if it means losing a patient.